Market Monitor – 23 October 2020
Insights

Market Monitor – 23 October 2020

Optimism about the ability of major western nations to bounce back quickly from the coronavirus pandemic was in short supply this week as concerns about a second wave of Covid-19 grew.

Global stock markets have extended their recent losses this week, with the second wave of Covid-19 taking an increasingly heavy toll on economies around the world. While the resurgence of the coronavirus in Europe and North America in particular is likely to lead eventually to additional stimulus measures from central banks, markets have again been disappointed by the continued failure of politicians in the United States to agree a new rescue package. The picture has not been entirely gloomy, however: there has been some positive economic news this week, with China becoming the first major economy to return to its pre-pandemic size – although third-quarter GDP figures came in somewhat short of expectations. Meanwhile, in the US, job losses appear to be slowing with the number of new unemployment claims this week falling to its lowest level since the start of the global health crisis. On the vaccine front, two of the major trials in the UK and US appear to be close to gaining regulatory approval. But investors remain aware that even if an effective vaccine becomes available before the end of 2020, the crisis is likely to continue for many months as a global inoculation programme is rolled out.

The US

On Wall Street, the Dow Jones Industrial Average ended trading on Thursday 0.8% down for the week so far, with the S&P 500 lower by 0.9% during the same time. Once again, stimulus talks between the Trump administration and the Democrat-led Congress have been investors’ main focus, with time running out for a deal to be agreed ahead of the presidential election at the start of November. Donald Trump appeared to reverse his recent position by calling for a bigger aid package but Republicans in Washington remain reluctant to approve such a large increase in spending. Meanwhile, coronavirus infection rates across the US are again on the up, raising fears that tougher lockdown policies could be imposed on a state-by-state basis.

The UK and Europe

In the UK, the FTSE 100 has endured another dismal few days, ending Thursday 2.3% down for the week – and dropping to its lowest level since the first half of May in the process. Shares in London are fighting on a number of fronts at the moment: as well as a rise in coronavirus cases and the introduction of strict new local lockdown rules around the country, the UK government is running out of time to agree a new trade deal with their counterparts in the European Union. Talks have now resumed after last week’s impasse, but businesses are increasingly resigned to facing a period of uncertainty – whether or not a deal is reached – after the implementation period ends on 31 December. There was some good news on Thursday, however, when chancellor Rishi Sunak announced improvements to the Job Support Scheme, which is due to come into effect at the start of November. The extra government subsidies for employers are designed to reduce the number of redundancies in the UK over the course of the winter, and were welcomed in particular by the more domestically focused FTSE 250 index. In Frankfurt, the DAX index ended Thursday’s session down 2.8% for the week as Covid-19 infection rates in Germany continued to rise, while France’s CAC 40 lost 1.7%. The International Monetary Fund this week warned central bankers in the eurozone that further stimulus measures would be needed if Europe’s major economies are to avoid a double-dip recession.
16/10/2020
22/10/2020
Change (%)
FTSE 100
5919.6
5785.7
-2.3
FTSE All-share
3325.7
3268.5
-1.7
S&P 500
3483.8
3453.5
-0.9
Dow Jones
28606.3
28363.7
-0.8
DAX
12909.0
12543.1
-2.8
CAC-40
4935.9
4851.4
-1.7
ACWI
583.1
579.9
-0.5

Note: all market data contained within the article is sourced from Bloomberg unless stated otherwise, data as at 22/10/2020.

23 October 2020
Mark King
Head of Investment Content
Share article
Share on linkedin
Share on email
Key topics
Related topics
Listen on Stitcher badge
Share article
Share on linkedin
Share on email
Key topics
Related topics

PDF

Market Monitor – 23 October 2020

Important information

Important information: Past performance is not a guide to future performance. Your capital is at risk. The value of investments and any income is not guaranteed and can go down as well as up and may be affected by exchange rate fluctuations. This means that an investor may not get back the amount invested. This document is not investment, legal, tax, or accounting advice. Investors should consult with their own professional advisors for advice on any investment, legal, tax, or accounting issues relating to an investment with Columbia Threadneedle Investments. The analysis included in this document has been produced by Columbia Threadneedle Investments for its own investment management activities, may have been acted upon prior to publication and is made available here incidentally. Any opinions expressed are made as at the date of publication but are subject to change without notice and should not be seen as investment advice. This document includes forward looking statements, including projections of future economic and financial conditions. None of Columbia Threadneedle Investments, its directors, officers or employees make any representation, warranty, guaranty, or other assurance that any of these forward-looking statements will prove to be accurate. Information obtained from external sources is believed to be reliable, but its accuracy or completeness cannot be guaranteed. Issued by Threadneedle Asset Management Limited. Registered in England and Wales, Registered No. 573204, Cannon Place, 78 Cannon Street, London EC4N 6AG, United Kingdom. Authorised and regulated in the UK by the Financial Conduct Authority. Columbia Threadneedle Investments is the global brand name of the Columbia and Threadneedle group of companies. columbiathreadneedle.com

Related Insights

4 December 2020

Mark King

Head of Investment Content

Market Monitor – 04 December 2020

An apparent end to post-election uncertainty in the United States allied to yet more positive vaccine news has driven stock markets to new highs last week.
Read time - 2 min
30 November 2020

Mark King

Head of Investment Content

Market Monitor – 30 November 2020

Global stock markets have struggled to hold on to their recent gains this week as a wave of new Covid-19 lockdown restrictions loomed, in Europe in particular.
Read time - 2 min
16 October 2020

Mark King

Head of Investment Content

Market Monitor – 16 October 2020

Global stock markets have struggled to hold on to their recent gains this week as a wave of new Covid-19 lockdown restrictions loomed, in Europe in particular.
Read time - 2 min
19 April 2024

Jim Griffin

Investment Content Manager

Market Monitor – 19 April 2024

A miserable month for global stock markets continued this week, with geopolitical concerns and further indications that central banks will be slow to cut interest rates adding to negative sentiment.
Read time - 3 min
12 April 2024

Jim Griffin

Investment Content Manager

Market Monitor – 12 April 2024

Global stock markets have endured another challenging week as a result of signs that policymakers are struggling to keep inflation in check in the United States.
Read time - 3 min
5 April 2024

Jim Griffin

Investment Content Manager

Market Monitor – 5 April 2024

Global stock markets had a difficult week following Easter, with conflicting economic data and further rises in commodity prices creating uncertainty for investors.
Read time - 3 min
true
true

Important information

Important information: Past performance is not a guide to future performance. Your capital is at risk. The value of investments and any income is not guaranteed and can go down as well as up and may be affected by exchange rate fluctuations. This means that an investor may not get back the amount invested. This document is not investment, legal, tax, or accounting advice. Investors should consult with their own professional advisors for advice on any investment, legal, tax, or accounting issues relating to an investment with Columbia Threadneedle Investments. The analysis included in this document has been produced by Columbia Threadneedle Investments for its own investment management activities, may have been acted upon prior to publication and is made available here incidentally. Any opinions expressed are made as at the date of publication but are subject to change without notice and should not be seen as investment advice. This document includes forward looking statements, including projections of future economic and financial conditions. None of Columbia Threadneedle Investments, its directors, officers or employees make any representation, warranty, guaranty, or other assurance that any of these forward-looking statements will prove to be accurate. Information obtained from external sources is believed to be reliable, but its accuracy or completeness cannot be guaranteed. Issued by Threadneedle Asset Management Limited. Registered in England and Wales, Registered No. 573204, Cannon Place, 78 Cannon Street, London EC4N 6AG, United Kingdom. Authorised and regulated in the UK by the Financial Conduct Authority. Columbia Threadneedle Investments is the global brand name of the Columbia and Threadneedle group of companies. columbiathreadneedle.com

You may also like

Investment approach

Teamwork defines us and is fundamental to our investment approach, which is structured to facilitate the generation, assessment and implementation of good, strong investment ideas for our portfolios.

Find your fund

Columbia Threadneedle Investments has a comprehensive range of investment funds catering for a broad range of objectives.

Types of investment

We offer a broad range of actively managed investment strategies and solutions covering global, regional and domestic markets and asset classes.